“By the end of the year, a highly specialized center dedicated to genomic analysis will be established in Palermo,” that is, the study of the entire genetic makeup of an individual or a microorganism, which makes it possible to map DNA in order to identify mutations, predispositions to disease, and guide targeted therapies.
This was stated by Massimo Midiri, president of Fondazione HEAL Italia, during the Forum organized by the Foundation in Palermo on 5th and 6th of june to take stock of the activities carried out in the field of precision medicine.
“We will bring to Palermo what is currently being done in some centers in Northern Italy and in the United States,” continued Midiri, who is also the Rector of the University of Palermo. “We will do it in Palermo through a simple blood sample for genomic analysis, which these extraordinary machines are able to perform, making it possible to detect at a very early stage diseases that might otherwise prove fatal. We will then follow these individuals throughout their entire care pathway.”
The Forum concluded with the presentation of the White Paper ‘Toward the Italian Strategy for Precision Medicine.’ “The PNRR ends on June 30, but we have already been assigned two funding lines worth several million euros for research, so the Foundation will continue its work,” said the president of HEAL Italia. “The goal is to create a paradigm shift toward a medicine no longer for everyone — that is, general medicine — but a medicine for each individual, a medicine that sees the single patient and places both the disease and the person at the center of attention,” Midiri concluded. “We must pay attention to those patients who present an altered genetic profile; it is on healthy individuals that we must begin to work, rather than waiting for the sick person.”
Credits: Ansa.it